Ketamine shows promise for rapid relief of suicidal ideation

NCT ID NCT02299440

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether ketamine, given as two infusions, can quickly reduce suicidal thoughts in 156 hospitalized patients at high risk for suicide. The main goal was to see if suicidal ideas resolved within 24 hours after the second dose. The approach aims to provide fast, short-term relief during a crisis.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUICIDAL IDEATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Suicidal Ideation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • APHP - Hôpital Lariboisière

    Paris, 75010, France

  • CHRU de Lille - Hôpital Michel Fontan

    Lille, 59037, France

  • CHRU de Montpellier - Hôpital Lapeyronie

    Montpellier, 34295, France

  • CHRU de Nîmes - Hôpital Universitaire Carémeau

    Nîmes, 30029, France

  • CHRU de Tours - Clinique Psychiatrique Universitaire

    Saint-Cyr-sur-Loire, 37540, France

  • CHU de Clermont Ferrand - Hôpital Gabriel-Montpied

    Clermont-Ferrand, 63003, France

  • CMME Centre Hospitalier Sainte Anne

    Paris, 75674, France

  • Centre Hospitalier Sainte-Anne

    Paris, 75674, France

  • Clinique Les Sophoras

    Nîmes, 30000, France